Advertisement
Review

HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling for Public Health Decision-Making in All Modes of Prevention and Evaluation

  • Wim Delva,

    Affiliation: South African Department of Science and Technology/National Research Foundation Centre for Excellence in Epidemiological Modelling and Analysis, University of Stellenbosch, Stellenbosch, South Africa

    X
  • David P. Wilson,

    Affiliation: Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia

    X
  • Laith Abu-Raddad,

    Affiliations: Infectious Disease Epidemiology Group, Weill Cornell Medical College—Qatar, Cornell University, Qatar Foundation—Education City, Doha, Qatar, Department of Public Health, Weill Cornell Medical College, Cornell University, New York, New York, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

    X
  • Marelize Gorgens,

    Affiliation: Global HIV/AIDS Program, The World Bank, Washington, District of Columbia, United States of America

    X
  • David Wilson,

    Affiliation: Global HIV/AIDS Program, The World Bank, Washington, District of Columbia, United States of America

    X
  • Timothy B. Hallett,

    Affiliation: Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom

    X
  • Alex Welte mail

    alexwelte@sun.ac.za

    Affiliation: South African Department of Science and Technology/National Research Foundation Centre for Excellence in Epidemiological Modelling and Analysis, University of Stellenbosch, Stellenbosch, South Africa

    X
  • Published: July 10, 2012
  • DOI: 10.1371/journal.pmed.1001239
  • Published in PLOS Medicine

About the Authors

Wim Delva, Alex Welte
South African Department of Science and Technology/National Research Foundation Centre for Excellence in Epidemiological Modelling and Analysis, University of Stellenbosch, Stellenbosch, South Africa
David P. Wilson
Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia
Laith Abu-Raddad
Infectious Disease Epidemiology Group, Weill Cornell Medical College—Qatar, Cornell University, Qatar Foundation—Education City, Doha, Qatar
Laith Abu-Raddad
Department of Public Health, Weill Cornell Medical College, Cornell University, New York, New York, United States of America
Laith Abu-Raddad
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
Marelize Gorgens, David Wilson
Global HIV/AIDS Program, The World Bank, Washington, District of Columbia, United States of America
Timothy B. Hallett
Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom

Corresponding Author

Email: alexwelte@sun.ac.za

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Wrote the first draft of the manuscript: WD DPW LA-R TH AW. Contributed to the writing of the manuscript: WD DPW LA-R DW MG TH AW. ICMJE criteria for authorship read and met: WD DPW LA-R DW MG TH AW. Agree with manuscript results and conclusions: WD DPW LA-R DW MG TH AW. Contributed to the conceptualisation and drafting of the article: WD DPW LA-R DW MG TH AW.